Help for Future Research: Lessons Learned in Trial Design, Recruitment, and Delivery From the “hELP” Study
(2018)
Journal Article
Simpson, R. C., Murphy, R., Bratton, D. J., Sydes, M. R., Wilkes, S., Nankervis, H., …Thomas, K. S. (2018). Help for Future Research: Lessons Learned in Trial Design, Recruitment, and Delivery From the “hELP” Study. Journal of Lower Genital Tract Disease, 22(4), 405-408. https://doi.org/10.1097/LGT.0000000000000407
All Outputs (6)
Identifying priority areas for research into the diagnosis, treatment and prevention of cellulitis (erysipelas): results of a James Lind Alliance Priority Setting Partnership (2017)
Journal Article
Thomas, K., Brindle, R., Chalmers, J., Gamble, B., Francis, N., Hardy, D., …Wilkes, S. (in press). Identifying priority areas for research into the diagnosis, treatment and prevention of cellulitis (erysipelas): results of a James Lind Alliance Priority Setting Partnership. British Journal of Dermatology, 177(2), https://doi.org/10.1111/bjd.15634
Is speed of healing a good predictor of eventual healing of pyoderma gangrenosum? (2016)
Journal Article
Wilkes, S. R., Williams, H. C., Ormerod, A. D., Craig, F. E., Greenlaw, N., Norrie, J., …Thomas, K. S. (2016). Is speed of healing a good predictor of eventual healing of pyoderma gangrenosum?. Journal of The American Academy of Dermatology, 75(6), 1216-1220.e2. https://doi.org/10.1016/j.jaad.2016.07.049Background: Pyoderma gangrenosum is a rare inflammatory skin condition. The STOPGAP studies compared treatments for pyoderma gangrenosum using a primary outcome of healing speed at 6 weeks. Objective: Using data from both studies we assessed the pre... Read More about Is speed of healing a good predictor of eventual healing of pyoderma gangrenosum?.
Is there an association between study size and reporting of study quality in dermatological clinical trials? A meta-epidemiological review (2016)
Journal Article
Ratib, S., Wilkes, S. R., Grainge, M. J., Tobinska, C., & Williams, H. C. (in press). Is there an association between study size and reporting of study quality in dermatological clinical trials? A meta-epidemiological review. British Journal of Dermatology, https://doi.org/10.1111/bjd.14931
How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema? (2016)
Journal Article
Wilkes, S. R., Nankervis, H., Tavernier, E., Maruani, A., & Williams, H. C. (2016). How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema?. Journal of Investigative Dermatology, 136(10), 1944-1949. https://doi.org/10.1016/j.jid.2016.05.104We sought to explore the architecture of trials of calcineurin inhibitors for atopic eczema to document the extent to which comparisons with active treatments such as topical corticosteroids (TCS) might have been included or avoided. We identified al... Read More about How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema?.
Skin and soft tissue infections and acute kidney injury: a systematic review (2015)
Journal Article
Wilkes, S., Selby, N., Robertson, F., Burden-Teh, E., & Grindlay, D. (2016). Skin and soft tissue infections and acute kidney injury: a systematic review. British Journal of Dermatology, 175(1), 182-184. doi:10.1111/bjd.14368